SOX9 and hepatocellular carcinoma: In conclusion, the results of our study indicated that SOX9 is a novel HCC-CSC marker regulating the Wnt/beta-catenin pathway and its downstream target OPN, and that OPN is a useful surrogate marker of SOX9 in HCC.